A detailed history of Rothschild Investment Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Rothschild Investment Corp holds 14,304 shares of BMRN stock, worth $931,047. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,304
Previous 15,004 4.67%
Holding current value
$931,047
Previous $1.3 Million 2.69%
% of portfolio
0.11%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

SELL
$85.07 - $94.48 $59,548 - $66,136
-700 Reduced 4.67%
14,304 $1.27 Million
Q2 2023

Jul 18, 2023

SELL
$86.68 - $100.3 $13,088 - $15,145
-151 Reduced 1.0%
15,004 $1.3 Million
Q1 2023

Apr 24, 2023

SELL
$87.74 - $117.27 $8,686 - $11,609
-99 Reduced 0.65%
15,155 $1.47 Million
Q4 2022

Jan 19, 2023

SELL
$80.93 - $108.63 $32,857 - $44,103
-406 Reduced 2.59%
15,254 $1.58 Million
Q3 2022

Oct 21, 2022

BUY
$82.16 - $96.94 $4,600 - $5,428
56 Added 0.36%
15,660 $1.33 Million
Q2 2022

Jul 12, 2022

BUY
$71.48 - $86.85 $75,054 - $91,192
1,050 Added 7.21%
15,604 $1.29 Million
Q4 2021

Jan 24, 2022

BUY
$71.72 - $91.47 $34,497 - $43,997
481 Added 3.42%
14,554 $1.29 Million
Q3 2021

Oct 12, 2021

SELL
$74.77 - $85.47 $22,431 - $25,641
-300 Reduced 2.09%
14,073 $1.09 Million
Q2 2021

Jul 19, 2021

SELL
$75.51 - $84.79 $32,091 - $36,035
-425 Reduced 2.87%
14,373 $1.2 Million
Q1 2021

Apr 15, 2021

BUY
$74.73 - $90.69 $14,946 - $18,138
200 Added 1.37%
14,798 $1.12 Million
Q4 2020

Jan 25, 2021

BUY
$72.61 - $90.2 $11,762 - $14,612
162 Added 1.12%
14,598 $1.28 Million
Q3 2020

Oct 22, 2020

SELL
$71.87 - $131.03 $206,985 - $377,366
-2,880 Reduced 16.63%
14,436 $1.1 Million
Q2 2020

Jul 24, 2020

SELL
$79.55 - $124.22 $78,993 - $123,350
-993 Reduced 5.42%
17,316 $2.14 Million
Q1 2020

Apr 16, 2020

SELL
$71.37 - $96.85 $29,261 - $39,708
-410 Reduced 2.19%
18,309 $1.55 Million
Q4 2019

Jan 22, 2020

BUY
$64.27 - $86.37 $96,405 - $129,555
1,500 Added 8.71%
18,719 $1.58 Million
Q3 2019

Oct 11, 2019

SELL
$67.4 - $85.11 $26,960 - $34,044
-400 Reduced 2.27%
17,219 $1.16 Million
Q2 2019

Jul 11, 2019

BUY
$80.35 - $93.9 $368,404 - $430,531
4,585 Added 35.18%
17,619 $1.51 Million
Q1 2019

Apr 18, 2019

BUY
$84.2 - $98.62 $8,420 - $9,862
100 Added 0.77%
13,034 $1.16 Million
Q4 2018

Jan 28, 2019

SELL
$80.14 - $106.07 $8,014 - $10,607
-100 Reduced 0.77%
12,934 $1.1 Million
Q3 2018

Oct 17, 2018

SELL
$93.92 - $105.72 $62,456 - $70,303
-665 Reduced 4.85%
13,034 $1.26 Million
Q1 2018

Apr 27, 2018

BUY
$77.67 - $92.63 $491,651 - $586,347
6,330 Added 85.9%
13,699 $1.11 Million
Q4 2017

Jan 23, 2018

BUY
$80.76 - $95.13 $595,120 - $701,012
7,369
7,369 $657,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.